Description: Resource papers that would be helpful to actuaries who work on Experience Studies and/or Table Development.

Description: This study quantifies the range of intercompany variability in mortality. Mean actual-to-expected (A/E) ratios based on amount were calculated in each quintile for every combination of six key variables.

Description: This paper compares two mortality projection models – the latest version of the CMI Mortality Projections Model and the latest version of MIM-2021.Both models were applied to data for England & Wales and the US, and the results were compared.

Description: A reference document which describes the table development process.

Description: The document is about the post-wildfire drinking water crisis and its implications for the insurance industry. It discusses the contamination of drinking water systems by wildfires, remediation strategies, financial considerations for the insurance industry, and potential contributions from the actuarial community.

Description: The definition of simplified issue business developed by the Society of Actuaries and the Academy of Actuaries.

Description: LIMRA, Reinsurance Group of America (RGA), the Society of Actuaries (SOA) Research Institute, and TAI have collaborated on an ongoing effort to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience and share the emerging results with the insurance industry and the public. This report contains the results of a cause of death analysis focused on how the rates of death for various causes were impacted throughout the pandemic period through the second quarter of 2022.

Description: A recommendation for a set of improvement factors that vary by gender and attained age to be used in conjunction with the 2008 Valuation Basic table or the 2015 Valuation Basic table for AG-38 purposes.

Description: Experience report for life insurance policies with face amounts of $1 million or higher.

Description: Summarizes the results of a follow-up survey of a panel of experts on COVID-19 to see how views on the disease’s impact on future U.S. mortality may have changed.